1. Home
  2. SFBC vs PLRX Comparison

SFBC vs PLRX Comparison

Compare SFBC & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SFBC
  • PLRX
  • Stock Information
  • Founded
  • SFBC 1953
  • PLRX 2015
  • Country
  • SFBC United States
  • PLRX United States
  • Employees
  • SFBC N/A
  • PLRX N/A
  • Industry
  • SFBC Savings Institutions
  • PLRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SFBC Finance
  • PLRX Health Care
  • Exchange
  • SFBC Nasdaq
  • PLRX Nasdaq
  • Market Cap
  • SFBC 112.5M
  • PLRX 97.6M
  • IPO Year
  • SFBC N/A
  • PLRX 2020
  • Fundamental
  • Price
  • SFBC $45.75
  • PLRX $1.58
  • Analyst Decision
  • SFBC
  • PLRX Hold
  • Analyst Count
  • SFBC 0
  • PLRX 10
  • Target Price
  • SFBC N/A
  • PLRX $9.79
  • AVG Volume (30 Days)
  • SFBC 6.1K
  • PLRX 1.2M
  • Earning Date
  • SFBC 07-29-2025
  • PLRX 08-06-2025
  • Dividend Yield
  • SFBC 1.65%
  • PLRX N/A
  • EPS Growth
  • SFBC 59.67
  • PLRX N/A
  • EPS
  • SFBC 2.44
  • PLRX N/A
  • Revenue
  • SFBC $38,045,000.00
  • PLRX N/A
  • Revenue This Year
  • SFBC N/A
  • PLRX N/A
  • Revenue Next Year
  • SFBC N/A
  • PLRX N/A
  • P/E Ratio
  • SFBC $18.90
  • PLRX N/A
  • Revenue Growth
  • SFBC 8.26
  • PLRX N/A
  • 52 Week Low
  • SFBC $43.00
  • PLRX $1.10
  • 52 Week High
  • SFBC $55.99
  • PLRX $16.10
  • Technical
  • Relative Strength Index (RSI)
  • SFBC 44.59
  • PLRX 58.70
  • Support Level
  • SFBC $44.00
  • PLRX $1.55
  • Resistance Level
  • SFBC $48.50
  • PLRX $1.61
  • Average True Range (ATR)
  • SFBC 1.28
  • PLRX 0.11
  • MACD
  • SFBC 0.14
  • PLRX 0.01
  • Stochastic Oscillator
  • SFBC 38.89
  • PLRX 80.00

About SFBC Sound Financial Bancorp Inc.

Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Share on Social Networks: